4
Changes in Ownership
Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-21-060760
EVP & Chief Commercial Officer sold 303 shares at $81.14 ($24,585)
From the SEC's structured data for this filing
Trades in this filing
Harris Erik · EVP & Chief Commercial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-10-14 | Sale : show line 1 in the form | −303 | $81.14 | $24,585 | 25,030 | D |
| Open-market sales · 303 sh · avg $81.14 · $24,585 | ||||||
Loading xslF345X03/doc4.xml…